These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16439136)

  • 1. Structural and functional characterization of human microsomal prostaglandin E synthase-1 by computational modeling and site-directed mutagenesis.
    Huang X; Yan W; Gao D; Tong M; Tai HH; Zhan CG
    Bioorg Med Chem; 2006 May; 14(10):3553-62. PubMed ID: 16439136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding microscopic binding of human microsomal prostaglandin E synthase-1 (mPGES-1) trimer with substrate PGH2 and cofactor GSH: insights from computational alanine scanning and site-directed mutagenesis.
    Hamza A; Tong M; AbdulHameed MD; Liu J; Goren AC; Tai HH; Zhan CG
    J Phys Chem B; 2010 Apr; 114(16):5605-16. PubMed ID: 20369883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PGH2 degradation pathway catalyzed by GSH-heme complex bound microsomal prostaglandin E2 synthase type 2: the first example of a dual-function enzyme.
    Yamada T; Takusagawa F
    Biochemistry; 2007 Jul; 46(28):8414-24. PubMed ID: 17585783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding microscopic binding of human microsomal prostaglandin E synthase-1 with substrates and inhibitors by molecular modeling and dynamics simulation.
    Hamza A; Abdulhameed MD; Zhan CG
    J Phys Chem B; 2008 Jun; 112(24):7320-9. PubMed ID: 18476739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine mPGES-1 3D structure elucidation and inhibitors binding mode predictions by homology modeling and site-directed mutagenesis.
    Corso G; Coletta I; Ombrato R
    J Chem Inf Model; 2013 Jul; 53(7):1804-17. PubMed ID: 23789712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homo-timeric structural model of human microsomal prostaglandin E synthase-1 and characterization of its substrate/inhibitor binding interactions.
    Xing L; Kurumbail RG; Frazier RB; Davies MS; Fujiwara H; Weinberg RA; Gierse JK; Caspers N; Carter JS; McDonald JJ; Moore WM; Vazquez ML
    J Comput Aided Mol Des; 2009 Jan; 23(1):13-24. PubMed ID: 18777160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal Structures of mPGES-1 Inhibitor Complexes Form a Basis for the Rational Design of Potent Analgesic and Anti-Inflammatory Therapeutics.
    Luz JG; Antonysamy S; Kuklish SL; Condon B; Lee MR; Allison D; Yu XP; Chandrasekhar S; Backer R; Zhang A; Russell M; Chang SS; Harvey A; Sloan AV; Fisher MJ
    J Med Chem; 2015 Jun; 58(11):4727-37. PubMed ID: 25961169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HTRF-based assay for microsomal prostaglandin E2 synthase-1 activity.
    Goedken ER; Gagnon AI; Overmeyer GT; Liu J; Petrillo RA; Burchat AF; Tomlinson MJ
    J Biomol Screen; 2008 Aug; 13(7):619-25. PubMed ID: 18626113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dynamic Asp-Arg interaction is essential for catalysis in microsomal prostaglandin E2 synthase.
    Brock JS; Hamberg M; Balagunaseelan N; Goodman M; Morgenstern R; Strandback E; Samuelsson B; Rinaldo-Matthis A; Haeggström JZ
    Proc Natl Acad Sci U S A; 2016 Jan; 113(4):972-7. PubMed ID: 26755582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular docking and competitive binding study discovered different binding modes of microsomal prostaglandin E synthase-1 inhibitors.
    He S; Lai L
    J Chem Inf Model; 2011 Dec; 51(12):3254-61. PubMed ID: 22077876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation of a critical arginine in microsomal prostaglandin E synthase-1 shifts the isomerase activity to a reductase activity that converts prostaglandin H2 into prostaglandin F2alpha.
    Hammarberg T; Hamberg M; Wetterholm A; Hansson H; Samuelsson B; Haeggstro M JZ
    J Biol Chem; 2009 Jan; 284(1):301-305. PubMed ID: 18984580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human microsomal prostaglandin E synthase-1: purification, functional characterization, and projection structure determination.
    Thorén S; Weinander R; Saha S; Jegerschöld C; Pettersson PL; Samuelsson B; Hebert H; Hamberg M; Morgenstern R; Jakobsson PJ
    J Biol Chem; 2003 Jun; 278(25):22199-209. PubMed ID: 12672824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the two-phase mechanism of arachidonic acid regulating inflammatory prostaglandin E2 biosynthesis by targeting COX-2 and mPGES-1.
    Akasaka H; Ruan KH
    Arch Biochem Biophys; 2016 Aug; 603():29-37. PubMed ID: 27177970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2.
    Murakami M; Naraba H; Tanioka T; Semmyo N; Nakatani Y; Kojima F; Ikeda T; Fueki M; Ueno A; Oh S; Kudo I
    J Biol Chem; 2000 Oct; 275(42):32783-92. PubMed ID: 10869354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure and possible catalytic mechanism of microsomal prostaglandin E synthase type 2 (mPGES-2).
    Yamada T; Komoto J; Watanabe K; Ohmiya Y; Takusagawa F
    J Mol Biol; 2005 May; 348(5):1163-76. PubMed ID: 15854652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human microsomal prostaglandin E synthase-1 (mPGES-1) binding with inhibitors and the quantitative structure-activity correlation.
    AbdulHameed MD; Hamza A; Liu J; Huang X; Zhan CG
    J Chem Inf Model; 2008 Jan; 48(1):179-85. PubMed ID: 18052142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights into the catalytic mechanism of Bombyx mori prostaglandin E synthase gained from structure-function analysis.
    Yamamoto K; Suzuki M; Higashiura A; Aritake K; Urade Y; Uodome N; Hossain T; Nakagawa A
    Biochem Biophys Res Commun; 2013 Nov; 440(4):762-7. PubMed ID: 24120949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of highly potent microsomal prostaglandin e2 synthase 1 inhibitors using the active conformation structural model and virtual screen.
    He S; Li C; Liu Y; Lai L
    J Med Chem; 2013 Apr; 56(8):3296-309. PubMed ID: 23527738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perspective of microsomal prostaglandin E2 synthase-1 as drug target in inflammation-related disorders.
    Koeberle A; Werz O
    Biochem Pharmacol; 2015 Nov; 98(1):1-15. PubMed ID: 26123522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexpression of microsomal prostaglandin E synthase with cyclooxygenase-2 in human rheumatoid synovial cells.
    Kojima F; Naraba H; Sasaki Y; Okamoto R; Koshino T; Kawai S
    J Rheumatol; 2002 Sep; 29(9):1836-42. PubMed ID: 12233875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.